SCYX Q1 2018 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$64,000+0.0% YoY

Gross Profit

$64,000100.0% margin

Operating Income

-$7M-11301.6% margin

Net Income

-$4M-6253.1% margin

EPS (Diluted)

$-1.19

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$425,000

Balance Sheet

Total Assets

$65M

Total Liabilities

$29M

Stockholders' Equity

$37M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64,000	$64,000	+0.0%
Gross Profit	$64,000	$64,000	+0.0%
Operating Income	-$7M	-$6M	-20.2%
Net Income	-$4M	-$5M	+17.8%